Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus

Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase

Expression of RIG-I, IRF3, IFN-beta and IRF7 determines resistance or susceptibility of cells to infection by Newcastle Disease Virus

Cross-infection of tumor cells by contact with T lymphocytes loaded with Newcastle disease virus

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study

Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer